The largest database of trusted experimental protocols

Steady glo substrate

Manufactured by Promega
Sourced in United States

Steady-Glo substrate is a luminescent reagent used for the detection and quantification of various biomolecules, such as proteins, enzymes, and reporter genes, in cell-based assays. It provides a stable and sustained luminescent signal, enabling reliable and reproducible measurements.

Automatically generated - may contain errors

8 protocols using steady glo substrate

1

Cell Culture Protocol with Selective Reagents

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following reagents were purchased from Invitrogen (Carlsbad, CA): Dulbecco’s Modified Eagle Medium (DMEM) high glucose (cat# 11965–085), Roswell Park Memorial Institute (RPMI) 1640 (cat# 11875–085), DMEM high glucose without phenol red (cat# 31053–028), RPMI 1640 without phenol red (cat# 11835–030), Glutamax 200 mM (x100) (Cat# 35050), G418 (Geneticin® Selective Antibiotic, cat# 11811–031), and StemPro Accutase Cell Dissociation Reagent (cat# A11105–01). Tet System Approved FBS, US-Sourced (cat# 631101) and Doxycyline (cat# 631311) were purchased from Clontech (Mountain View, CA). Puromycin dihydrochloride from Streptomyces alboniger (cat# P8833–25MG) was purchased from Sigma-Aldrich (St. Louis, MO) and Steady-Glo substrate (cat# E2550) was purchased from Promega (Madison, WI).
+ Open protocol
+ Expand
2

Cell Culture Protocol with Selective Reagents

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following reagents were purchased from Invitrogen (Carlsbad, CA): Dulbecco’s Modified Eagle Medium (DMEM) high glucose (cat# 11965–085), Roswell Park Memorial Institute (RPMI) 1640 (cat# 11875–085), DMEM high glucose without phenol red (cat# 31053–028), RPMI 1640 without phenol red (cat# 11835–030), Glutamax 200 mM (x100) (Cat# 35050), G418 (Geneticin® Selective Antibiotic, cat# 11811–031), and StemPro Accutase Cell Dissociation Reagent (cat# A11105–01). Tet System Approved FBS, US-Sourced (cat# 631101) and Doxycyline (cat# 631311) were purchased from Clontech (Mountain View, CA). Puromycin dihydrochloride from Streptomyces alboniger (cat# P8833–25MG) was purchased from Sigma-Aldrich (St. Louis, MO) and Steady-Glo substrate (cat# E2550) was purchased from Promega (Madison, WI).
+ Open protocol
+ Expand
3

Adenovirus Neutralization Antibody Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Adenovirus-specific neutralization antibody (NAb) titers using mouse serum samples were conducted as previously described (31 (link)). Briefly, serum was 2-fold serially diluted in a 96-well flat-bottom plate, with the exception of the last column, which served as the maximum-infection control. Replication-incompetent recombinant Ad-Luc reporter construct viruses were added to the plate, followed by the addition of A459 cells. The plates were incubated for 24 h at 37°C in 10% CO2. After incubation, the medium was removed and 100 μl of phosphate-buffered saline (PBS) and 100 μl of Steady-Glo substrate (Promega) were added to the wells. The luciferase (Luc) activity in the cells was measured with a Victor 3 multilabel counter (PerkinElmer, Waltham, MA). Neutralization titers were defined as the maximum serial dilution where 90% of the virus was neutralized by the serum.
+ Open protocol
+ Expand
4

Transfection and Silencing Assays in Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293T cells were co-transfected with reporter vectors along with other expression vectors or molecular clones using Lipofectamine 2000 (Invitrogen, USA) and harvested 36 h post-transfection for luciferase assay. The cells were lysed in cell lysis reagent (Promega, USA) and luciferase assays were performed using Steady-Glo substrate (Promega, USA) as described earlier (30 (link)). Jurkat cells were transfected using x-treme gene HP DNA transfection reagent (Roche Applied Bioscience, Germany).
For silencing studies, cells were first transfected with siRNA using Lipofectamine 2000 as per the manufacturer's instructions, followed by second transfection (reporter plasmid/ expression vectors) or infection as described earlier (52 (link)). Cells were harvested 48 h post-transfection/infection. Knockdown was confirmed by immunoblotting with respective antibodies. Immunoblotting with GAPDH served as the loading control.
+ Open protocol
+ Expand
5

AvBD9 Promoter-Driven Luciferase Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
HTC cells were seeded overnight in 24-well tissue culture plates before being transfected with 50 ng/well of different AvBD9 promoter-driven luciferase reporter plasmids using FuGENE HD Transfection Reagent (Promega). After 24 h, cells were stimulated in duplicate with or without 8 mM sodium butyrate for another 24 h. Luciferase activity was measured by adding an equal volume of Steady-Glo Substrate to each well for 10 min using Steady-Glo Luciferase Assay System (Promega) according to the manufacturers' instructions. The luminescence was detected using Modulus Single-Tube Luminometer (Turner Biosystems, Sunnuvale, CA).
+ Open protocol
+ Expand
6

Ad5-Specific Neutralizing Antibody Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ad5-specific neutralizing antibodies were measured using a luciferase-based neutralization assay as previously described (51 (link)). Briefly, serum from treated mice was serially diluted, Ad5.Luc virus was added, and the mixture was added to A549 cells. Following 24 h of incubation, medium was removed and 100 μl PBS and 100 μl Steady-Glo substrate (Promega) were added to wells. Luminescence was read on a Victor 3 multilabel counter (PerkinElmer), and the 90% inhibitory concentration (IC90) was determined (dilution of serum at which 90% of Ad5.Luc was neutralized).
+ Open protocol
+ Expand
7

Screening and Characterization of BNBC

Check if the same lab product or an alternative is used in the 5 most similar protocols
HepAD38/cGAS-STING/ISG54Luc cells, HepAD38/cGAS STINGΔC/ISG54Luc cells or HepG2/STING/ISG54Luc cells were seeded in black wall/clear bottom 96-well plates at a density of 4×104/well in 0.1 mL of medium for overnight. HTS and hit identification were as described previously49 (link). To determine the activity of BNBC, the cells were treated with 1% DMSO (mock treated control) or indicated concentrations of BNBC (or its analogs) for 4 h. The firefly luciferase activities were measured by using Steady-Glo substrate (Promega) with TopCount (Perkin Elmer)49 (link).
+ Open protocol
+ Expand
8

Luminescence-based Nrf2 Pathway Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
100 µL of a cell suspension (10 5 cells/mL) were added to 96 well plates and incubated for 24 ± 4 h at 37 °C in a humidified atmosphere with 5% CO 2 . Afterwards, the medium got replaced by 50 µL of the sample or dissolved chemicals. The plates were covered with sealing film and incubated for 6 h at 37 °C and 5% CO 2 .
For measurement of the viability, Steady-Glo ® substrate (Promega) was dissolved in the corresponding buffer and further diluted 1:10 with RO-H 2 O to a final concentration of 1.54 mg/mL. 50 µL of the Steady-Glo ® solution were added to the wells and luminescence measured with a plate reader (Victor 3 , Perkin Elmer).
Afterwards, for measurement of sensitization, the Nano-Glo ® Luciferase substrate was diluted 1:50 in the corresponding buffer and further diluted 1:10 in PBS containing 1.5% EDTA. 50 µL of this solution was added to the wells and luminescence measured with a plate reader (Victor 3 , Perkin Elmer).
Fold inductions were calculated as the ratio of the relative light units of the samples to the relative light units of untreated PBS + 1% DMSO. A fold induction above 2 was counted as significant activation of the ARE-Nrf2 pathway.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!